The efficacy and predictive factors of first-line immune checkpoint inhibitors for advanced non-small cell lung cancer with driver or non-driver gene alterations: a retrospective cohort study.

J Thorac Dis · 2026 · PMC12876016 · PMID 41660470

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP=0.10so close (0.05 < p ≤ 0.1)

Although baseline bone metastasis was associated with worse PFS in the multivariate model, it did not reach statistical significance (HR 1.75, 95% CI: 0.902–3.38, P=0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.